Aurobindo to produce Gilead meds in HIV pool; Sanofi inaugurates Irish Genzyme expansion;

@FiercePharma: Merck persuaded an Australian appeals court to overturn a Vioxx damages award of $259,400 News | Follow @FiercePharma

> Aurobindo Pharma joined the Medicines Patent Pool for production of AIDS drugs, in a deal that would allow the Indian drugmaker to turn out a range of HIV fighters licensed to the pool by Gilead Sciences. Article

> Sanofi ($SNY) CEO Christopher Viehbacher and Irish officials inaugurated a €150 million expansion at the French drugmaker's Genzyme facility in Waterford, Ireland. News

> The Belgian drug ingredients and dental device company Arseus was approached about a takeover, local media says, but executives called the reports market speculation. Report

> Edgemont Pharmaceuticals won the FDA nod for its 60-mg dose of fluoxetine, the generic version of Eli Lilly's ($LLY) antidepressant Prozac. Story

> Analysts changed their ratings on Vertex Pharmaceuticals ($VRTX), with JMP Securities upgrading the stock to "outperform" and a $53 price target and Bank of America lowering its target to $55. Report

> Better HIV drugs and earlier diagnoses pushed patients' life expectancy up by 15 years between 1996 and 2008, a study found. News

> Fitch Ratings affirmed AstraZeneca's ($AZN) debt rating at AA- and called the company outlook "stable." Story

Biotech News

@FierceBiotech: Pfizer, Exonhit partner on Alzheimer's biomarkers. More | Follow @FierceBiotech

@ JohnCFierce: In their settlement deal--spelled out in an 8K--Onyx gets U.S. co-promo rights to regorafenib. | Follow @JohnCFierce

@RyanMFierce: I saw twitter action on this fertility startup OvaScience a while ago, but @scottkirsner is 1st to write an article Article | Follow @RyanMFierce

 @MaureenFierce: @LifeSciVC: E&Y says 44% of drugs in dev are for oncology. @dereklowe asks, is that too many, too few or just right? Article Follow @MaureenFierce

> Bayer settles Onyx spat with $160M payout, sales rights and royalties. Piece

Medical Device News

> Report: Cook stent meets safety, effectiveness goals. Item

Drug Delivery News

> Nano-therapy that cooks deadly brain tumors advances in Germany. More

> Unigene forms joint venture to develop oral peptide drugs with Nordic Bioscience. Story

> Zosano inks Asian deal worth $32.5M-plus for drug patch tech. Report

And Finally... Men taking daily Vitamin E supplements were more likely to get prostate cancer, a study found. Article

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.